preclinical news from FierceBioResearcher
NewsNew vaccine may stop, slow Alzheimer's
Scientists at Oklahoma Medical Research Foundation are reporting success in advancing an experimental, preclinical vaccine that can prevent or slow Alzheimer's. The researchers, led by Dr. Jordan Read more...
Hollis-Eden spurs stock price with preclinical news
It's not often that you see a set of preclinical data influence a company's stock price, but Read more...
| Press ReleasesPRESS RELEASE: Hollis-Eden Pharmaceuticals Presents HE3235 Update at ASCO Breast Cancer Symposium Hollis-Eden Pharmaceuticals Presents HE3235 Update at ASCO Breast Cancer Symposium Preclinical Data Show Lasting Anti-Tumor Effect of Novel Drug Candidate SAN DIEGO -- Hollis-Eden Pharmaceuticals, Read more... PRESS RELEASE: FermaVir Announces Positive Data from Recent Preclinical Studies of FV-100FermaVir Announces Positive Data from Recent Preclinical Studies of FV-100 FermaVir Pharmaceuticals, Inc. today announced positive results from preclinical studies evaluating FV-100, a highly potent, Read more... |
Get more preclinical coverage at:
Paid Research Reports
- Pipeline Insight: Nosocomial Vaccines - Minefield or Goldmine?
- Drug Approval Trends at the FDA and EMEA: Process improvements, heightened scrutiny and industry response
- Biotech 2008 – life sciences industry report (online & print)
- Is there a market for alcoholism pharmacotherapies?
- New report provides Rheumatoid Arthritis market insight